Delivery Order SPE2DB22D3301-SPE2DB24FX5QX
- Not listed
- This federal contract award, identified as SPE2DB22D2006|SPE2DB24FW0YH, was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,107.19, is for the delivery of Sucralfate 1 GM Tablet 90S, a pharmaceutical product, to support federal healthcare programs. The contract is a Delivery Order issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA...
- This federal contract award, SPE2DB22D3301|SPE2DB25FY3RW, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,782.12 firm fixed-price delivery order is for the supply of 4,568,000 Sucralfate 1 GM Tablet 90S, a medication used to treat peptic ulcers. The contract has an ultimate completion date of April 23, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp...
- This federal contract award, with ID SPE2DB22D2211|SPE2DB25FRQXR, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,491.67 firm fixed-price delivery order is for the supply of 420 ml of Sucralfate 1 gm/10 ml suspension, a medication used to treat certain stomach and esophageal conditions. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
- This federal contract award, valued at $3,918.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Sucralfate 1 GM Tablets in 90-count packages. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of November 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,738.59, is for the delivery of sucralfate 1 gram tablets in quantities of 90 per bottle. The contract has an ultimate completion date of November 30, 2023 and is structured as a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite...
- This federal contract award, valued at $12,277.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of sucralfate 1 gram tablets, a medication used to treat various gastrointestinal conditions. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 26, 2024. Amerisourcebergen holds a significant Indefinite Delivery...
- This is a federal contract award by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,986.98, is a delivery order for the supply of 4,563,081,429 units of Sucralfate 1 GM Tablets in 90-count bottles. The contract has an ultimate completion date of December 13, 2023 and is a firm fixed-price arrangement. AmerisourceBergen Drug Corp is a for-profit organization...
- This federal contract award, valued at $2,196.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Sucralfate 1 GM/10 ML Suspension, a pharmaceutical product, and has a completion date of May 14, 2025. The contract is a delivery order, with a firm fixed-price pricing type, and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 420 ml bottles of 1 gm/10 ml sucralfate suspension. The $4,416.88 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the company holds with DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract, which runs through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Sucralfate 1 gm/10 ml suspension. The $4,597.18 firm fixed price contract has a completion date of June 23, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FX5QXDelivery Order
This federal contract award, with ID SPE2DB22D3301|SPE2DB24FX5QX, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,649.58 firm fixed-price delivery order is for the supply of 4562866151 - Sucralfate 1 GM Tablet 90s, with a period of performance ending on November 21, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC, running through November 2026, encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.6k | 11/20/23 |